Type of sarcoma: Soft tissue sarcoma, bone sarcoma
Full title: Phase I-II Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas
Age: 12-80
Phase: 1 and 2
Locations: University College London Hospitals NHS Foundation Trust
The trial is a phase II, single-arm, six-cohort, non-randomized, open-label, multicentre prospective study.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
